Cross-Tapering from Venlafaxine (Effexor) to Mirtazapine
When switching from venlafaxine to mirtazapine, perform a gradual taper of venlafaxine over 10-14 days while simultaneously starting mirtazapine at low dose, as venlafaxine requires tapering to prevent withdrawal syndrome while mirtazapine can be safely initiated during the taper.
Rationale for Cross-Taper Approach
Venlafaxine (an SNRI) requires careful discontinuation because withdrawal syndrome has been well-documented 11. The FDA label explicitly states that "a gradual reduction in the dose rather than abrupt cessation is recommended whenever possible" and that "symptoms associated with discontinuation of Effexor XR have been reported" 2. In contrast, mirtazapine has a different mechanism of action (alpha-2 antagonist, not an SNRI) and does not require washout periods between antidepressants.
Specific Tapering Schedule
Week 1-2: Initiate the Cross-Taper
Venlafaxine reduction:
- Reduce current venlafaxine dose by 75 mg per week 2
- If on 150 mg/day: reduce to 75 mg/day for week 1
- If on 225 mg/day: reduce to 150 mg/day for week 1, then 75 mg/day for week 2
Mirtazapine initiation:
- Start mirtazapine 7.5 mg at bedtime during the first week of venlafaxine taper 33
- Increase to 15 mg at bedtime after 3-5 days if tolerated
- Target dose is 15-30 mg at bedtime 33
Week 2-3: Complete Venlafaxine Discontinuation
- Continue reducing venlafaxine by 75 mg weekly until discontinued 2
- Maintain mirtazapine at 15-30 mg at bedtime
- Monitor closely for withdrawal symptoms during final venlafaxine discontinuation
Critical Warnings
Do NOT use alternate-day dosing when tapering venlafaxine. Recent evidence demonstrates that alternate-day dosing causes pronounced receptor occupancy variation and significantly increases withdrawal risk 4. This approach cannot be recommended as a prudent tapering strategy.
Monitor for venlafaxine withdrawal symptoms:
- Dizziness, nausea, headache, irritability, insomnia, sensory disturbances
- If intolerable symptoms occur, resume the previous venlafaxine dose and taper more gradually 2
- Consider extending the taper to 3-4 weeks in patients on higher doses (>150 mg/day) or longer treatment duration
Advantages of This Approach
This cross-taper strategy is supported by research showing that switching to or augmenting with mirtazapine from other antidepressants is feasible and effective 56. Mirtazapine's sedating properties (promoting sleep and appetite) 33 can actually help counteract some venlafaxine withdrawal symptoms like insomnia and agitation.
No washout period is required between venlafaxine and mirtazapine because they have different mechanisms of action and no significant drug interactions. The FDA label specifies washout requirements only for MAOIs (7 days after stopping venlafaxine) 2, not for other antidepressants.
Monitoring During Transition
- Assess withdrawal symptoms weekly during the taper
- Evaluate depressive symptom response at 4 weeks on mirtazapine 33
- Common mirtazapine side effects include sedation, increased appetite, and weight gain 33
- Mirtazapine dosing is straightforward: most patients respond to 15-30 mg at bedtime, with maximum dose of 30 mg 33